You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股收評:滬指縮量跌0.29%,新冠檢測板塊大漲,光伏、儲能概念反彈

今日,兩市縮量下跌,市場表現較為謹慎,題材概念整體活躍度不高。截止收盤,滬指跌0.29%報3156點,深成指跌0.39%,創業板指漲0.09%。兩市3012股上漲,1818股下跌,成交額8600億,北上資金淨買入40.9億,為連續4天淨買入。

盤面上,廣州鼓勵家庭自備抗原試劑盒,新冠檢測概念全天強勢,賽力醫療等多股漲停;儲能、光伏、特高壓等新能源電力方向個股表現相對活躍,陽光電源漲3.6%;豬肉、雞肉概念午後拉昇,温氏股份漲3%;信創、國資雲、雲計算等概念早盤衝高後回落,科華數據漲停再創新高。倉儲物流、航空航天、有色等板塊跌幅靠前,地產股走勢分化,中交地產、信達地產等股跌停,財信發展等7股漲停。

具體來看:

汽車股跌幅居前,中國重汽跌超6%,一汽解放跌超5%,賽力斯、東風汽車跌超4%,中通客車、海馬汽車等跟跌。

地產股繼續回調,中交地產、信達地產跌停,南國置業、天保基建、中國武夷跌超9%,渝開發、粵宏遠A跌超8%,光大嘉寶跌超7%,中國國貿、沙河股份跌超6%。

航運股走低,中原還能跌超9%,招商輪船跌超5%,盛航股份跌超4%,中遠海特、招商南油跌超3%。

燃氣、煤炭股走弱,佛燃能源跌超4%,德龍匯能跌超3%,九豐燃氣、陝西煤業、神火股份跌超2%。

抗原檢測概念股漲幅居前,盛通股份、賽力醫療漲停,優寧維漲超7%,萬孚生物、熱景生物漲超5%。

消息面上,廣州衞生健康委張屹稱,鼓勵家庭自備抗原試劑盒。有媒體稱,大參林等多家藥店均無抗原檢測試劑售賣,多家藥店稱“正在進貨中”。國聯證券指出,根據防控實施辦法及風險區劃定方案等政策,結合國內部分疫情地區情況,新冠抗原檢測試劑或將成為重要防疫補充工具,對應專業、非專業場景空間為112-260億元和150億元。

光伏、儲能概念股反彈,永福股份漲超17%,天洋新材、意華股份等漲停,金盤科技、新風光漲超6%。

消息面上,近日有網傳消息稱,現在市場上250元/千克的多晶硅緻密料基本無人問津,買方都在持幣觀望。對此,通威股份迴應,公司硅料滿產滿銷,目前價格沒變化,近期將確認12月價格。海通證券電新團隊認為,12月-明年1月,光伏行業將出現拐點。硅料價格可能在12月大幅下跌,與去年12月硅料從27萬下跌至21萬劇本雷同:1)國內搶裝接近收尾;2)降庫存壓力;3)這個月產業鏈博弈性最強。

虛擬數據人、Web 3.0等板塊走強,會暢通訊漲超13%,華揚聯眾漲停,拓爾思漲超5%,開普雲、東方國信、新致軟件等漲超4%。

啤酒概念股走強,惠泉啤酒漲超5%,珠江啤酒、燕京啤酒、重慶啤酒等跟漲。

北向資金方面,北上資金淨流入63.78億元,其中滬股通淨流入14.23億元,深股通淨流入49.55億元。

展望未來,中泰證券認為,“暖冬行情”在11月下旬短期震盪後仍將延續,結構上將由第一階段的指數行情向“權重搭台,個股唱戲”以中證1000為主的結構性行情演繹,後續關注點在於國內各項政策的發力。估值修復進程上推薦的配置方向:1)軍工板塊,軍工主機廠股權激勵等改革在四季度落地概率較高;2)數字貨幣板塊,計算機產業趨勢、國家金融安全和人民幣國際化存在共振驅動;3)穩增長-新基建相關的電力、特高壓、電網改造等板塊目前處在底部階段,同時也有不錯的景氣度;4)全面註冊制下相關配套設施和利好政策或相繼落地,利好資本市場發展,建議關注權重股中的券商板塊。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account